Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

Abstract

In severe, stable COPD, PDE4 inhibition with roflumilast produced a modest but significant improvement in lung function without changing the exacerbation rate or health status. However, patients with very severe disease experienced fewer exacerbations with roflumilast.